[go: up one dir, main page]

RU97106986A - MEANS AND METHOD FOR TREATING ISCHEMIC STROKE - Google Patents

MEANS AND METHOD FOR TREATING ISCHEMIC STROKE

Info

Publication number
RU97106986A
RU97106986A RU97106986/14A RU97106986A RU97106986A RU 97106986 A RU97106986 A RU 97106986A RU 97106986/14 A RU97106986/14 A RU 97106986/14A RU 97106986 A RU97106986 A RU 97106986A RU 97106986 A RU97106986 A RU 97106986A
Authority
RU
Russia
Prior art keywords
pro
ischemic stroke
treating ischemic
heptapeptide
glu
Prior art date
Application number
RU97106986/14A
Other languages
Russian (ru)
Other versions
RU2124365C1 (en
Inventor
Е.И. Гусев
В.И. Скварцова
Е.Ю. Журавлева
Л.А. Андреева
В.Н. Незавибатько
И.А. Гривенников
Н.Ф. Мясоедов
Original Assignee
Институт молекулярной генетики РАН
Filing date
Publication date
Application filed by Институт молекулярной генетики РАН filed Critical Институт молекулярной генетики РАН
Priority to RU97106986A priority Critical patent/RU2124365C1/en
Priority claimed from RU97106986A external-priority patent/RU2124365C1/en
Application granted granted Critical
Publication of RU2124365C1 publication Critical patent/RU2124365C1/en
Publication of RU97106986A publication Critical patent/RU97106986A/en

Links

Claims (4)

1. Применение гептапептида Met-Glu-His-Phe-Pro-Gly-Pro в качестве средства лечения ишемического инсульта.1. The use of the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a treatment for ischemic stroke. 2. Способ лечения ишемического инсульта путем применения раствора пептидов, отличающийся тем, что используют раствор гептапептида Met-Glu-His-Phe-Pro-Gly-Pro в воде или физиологическом растворе путем его интраназального введения. 2. A method of treating ischemic stroke by using a peptide solution, characterized in that a solution of the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro in water or physiological saline by intranasal administration is used. 3. Способ лечения ишемического инсульта по п.2, отличающийся тем, что для больных средней тяжести и при тяжелых инсультах используют гептапептид Met-Glu-His-Phe-Pro-Gly-Pro, соответственно, в суточной дозе 9-13 мг и 15-24 мг, в течение 8-12 сут. 3. A method of treating ischemic stroke according to claim 2, characterized in that for patients of moderate severity and in severe strokes heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro is used, respectively, in a daily dose of 9-13 mg and 15 -24 mg, for 8-12 days. 4. Способ лечения ишемического инсульта по пп.2 и 3, отличающийся тем, что гептапептид Met-Glu-His-Phe-Pro-Gly-Pro используют в виде 4-6%-ного раствора и вводят по 1-4 капли в каждый носовой ход 1-4 раза в сут. 4. A method of treating ischemic stroke according to claims 2 and 3, characterized in that the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro is used as a 4-6% solution and 1-4 drops are administered in each nasal passage 1-4 times a day.
RU97106986A 1997-05-13 1997-05-13 Method for treating the cases of ischemic insult RU2124365C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97106986A RU2124365C1 (en) 1997-05-13 1997-05-13 Method for treating the cases of ischemic insult

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97106986A RU2124365C1 (en) 1997-05-13 1997-05-13 Method for treating the cases of ischemic insult

Publications (2)

Publication Number Publication Date
RU2124365C1 RU2124365C1 (en) 1999-01-10
RU97106986A true RU97106986A (en) 1999-06-20

Family

ID=20192473

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97106986A RU2124365C1 (en) 1997-05-13 1997-05-13 Method for treating the cases of ischemic insult

Country Status (1)

Country Link
RU (1) RU2124365C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2251429C2 (en) * 2002-12-30 2005-05-10 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Pharmaceutical composition for treating ischemic insult and method for therapy
RU2258521C1 (en) * 2004-03-19 2005-08-20 ЗАО "РеМеТэкс" Biotransplant and method for treating ischemic insult
RU2324481C1 (en) * 2006-10-17 2008-05-20 Вероника Игоревна Скворцова Method of preventive treatment of stroke
RU2383615C1 (en) * 2009-03-12 2010-03-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Method of screening pharmacological compounds according to neuroprotective activity
RU2383619C1 (en) * 2009-03-12 2010-03-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Method for assessment of neurotrophin genes expression
RU2670203C1 (en) * 2018-03-13 2018-10-19 Общество с ограниченной ответственностью "СупраГен" Method for treatment of ischemic stroke

Similar Documents

Publication Publication Date Title
RU94016393A (en) PEPTIDES possessing the ability to stimulate the growth of the growth hormone, method of production, pharmaceutical composition, method of treatment
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
EP1005274A4 (en) Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
DE69914084D1 (en) PHENYLACETYLGLUTAMINE, PHENYLACETYLISOGLUTAMINE, AND / OR PHENYLACETATE FOR TREATING NEOPLASTIC DISEASES
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
RU97106986A (en) MEANS AND METHOD FOR TREATING ISCHEMIC STROKE
TR199801184T2 (en) New compounds with analgesic action.
RU2001118219A (en) ANGIOGENESIS INHIBITOR
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU96122561A (en) METHOD FOR COMPLEX THERAPY OF DISEASES
DE69428797D1 (en) USE OF BENZYDAMINE TO TREAT DISEASES CAUSED BY TNF
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
RU92004986A (en) METHOD OF CONSERVATIVE TREATMENT OF PERTES'S DISEASE
MA26796A1 (en) AMINOTETRALIN DERIVATIVE FOR THERAPY OF CARDIOVASCULAR DISEASES.
AR008155A1 (en) USE OF A COMPOUND OF FORMULA I TO PREPARE A USEFUL MEDICINE TO TREAT AND PREVENT POST MENOPAUSIC CARDIOVASCULAR DISEASE IN WOMEN.
RU97110054A (en) METHOD FOR TREATING DIABETIC STOP SYNDROME
ES2068369T3 (en) NA +, K + -ATPASE INHIBITOR FACTOR DIFFERENT FROM DIGOXIN.
RU2000118509A (en) A method for the treatment of neovasculogenesis after end-to-end keratoplasty
DK0580782T3 (en) Anti-HIV Protein, TAP 29, from Trichosanthes, Coding DNA, and Therapeutic Uses thereof
RU94045661A (en) Method of organism clearance
RU95103276A (en) Method for producing water-soluble extract for bath from tibetan species "taban arshan"
RU94013606A (en) Hemostimulator
RU95121400A (en) METHOD FOR TREATMENT OF RECURRENT SINUITES WITH APPLICATION OF BACTERICID-FUNGICID DEPOT DRUG
RU98109753A (en) METHOD FOR TREATING EXTRASYSTOLIA AND PAROXISMAL TACHYCARDIA